Bone · 2014 · 39 citations · 54 references
MedicineEndocrinologyImmunologyBone MetabolismImmunopathologyImmunotherapyBone DevelopmentBone FormationBone GrowthBone HealthBone Metabolism PharmacotherapySkeletal DevelopmentBone Resorption InhibitionDrug Effects On Bone DensityRank Ligand InhibitionRankl SignalingRankl-mediated Bone DestructionRankl-mediated Osteoclastogenesis
54
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Young‐Yun Kong, Hiroki Yoshida, Ildiko Sarosi et al. · Nature · 1999 · 3.4K citations
Medicine, Cell Biology, Immunology +14
RANK is essential for osteoclast and lymph node development
William C. Dougall, Moira Glaccum, K Charrier et al. · Genes & Development · 1999 · 1.5K citations · Full text
Sant P. Chawla, Robert M. Henshaw, Leanne L. Seeger et al. · The Lancet Oncology · 2013 · 583 citations
Medicine, Oncology, Pediatrics +12
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Karin Loser, Annette Mehling, Stefanie Loeser et al. · Nature Medicine · 2006 · 394 citations
Denosumab treatment for fibrous dysplasia
Alison M. Boyce, William H Chong, Jack Yao et al. · Journal of Bone and Mineral Research · 2012 · 263 citations · Full text